Effect of Postthrombotic Syndrome on Health-related Quality of Life After Deep Venous Thrombosis
Overview
Authors
Affiliations
Background: Postthrombotic syndrome (PTS) is a frequent chronic complication of deep venous thrombosis, yet its impact on health-related quality of life has not been well characterized. We compared generic and venous disease-specific quality of life in patients with and without PTS, and assessed whether quality of life correlated with severity of PTS.
Methods: Subjects with previous deep venous thrombosis were participants in a study of the effects of exercise after deep venous thrombosis. We ascertained PTS and its severity using a validated clinical scale. Subjects completed generic (the 36-Item Short-Form Health Survey) and disease-specific (Venous Insufficiency Epidemiologic and Economic Study quality-of-life questionnaire [VEINES-QOL] and its validated subscale of 10 items on venous symptoms [VEINES-Sym]) quality-of-life measures. Age- and sex-adjusted mean quality-of-life scores were compared in patients with and without PTS, and by severity of PTS.
Results: Of the 41 subjects (mean age, 51.2 years), 19 (46%) had PTS. Subjects with PTS had significantly worse disease-specific quality-of-life scores than those without PTS (mean +/- SD VEINES-QOL score, 44.5 +/- 11.6 vs 54.8 +/- 5.4, respectively [P<.001]; mean +/- SD VEINES-Sym score, 45.6 +/- 11.4 vs 54.1 +/- 6.7, respectively [P =.003]), which worsened significantly with increasing severity of PTS. We found no differences in generic quality-of-life scores between subject groups.
Conclusions: Postthrombotic syndrome has a significant impact on disease-specific quality of life that may not be captured by generic quality-of-life measures. Patient-based quality-of-life measures correlated well with physician-assessed PTS. Further research is indicated to assess the value of including quality of life as a routine measure of outcome in clinical studies of patients with deep venous thrombosis and PTS.
Haladyj E, Matusiewicz A, Wysocki T, Olesinska M Reumatologia. 2024; 62(4):266-273.
PMID: 39381730 PMC: 11457315. DOI: 10.5114/reum/192028.
Al-Mannai N, Sibira D, Alsuwaidi H, Elmagdoub A, Habas E, Alfitori G Clin Case Rep. 2024; 12(10):e9263.
PMID: 39328294 PMC: 11423260. DOI: 10.1002/ccr3.9263.
Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review.
Attaran R, Carr J J Soc Cardiovasc Angiogr Interv. 2024; 2(1):100538.
PMID: 39132527 PMC: 11307564. DOI: 10.1016/j.jscai.2022.100538.
Morrison L, Smoody B, Woltjer R, Hinds M, Loftis J, Wyatt C Thromb Res. 2024; 240:109063.
PMID: 38878741 PMC: 11239555. DOI: 10.1016/j.thromres.2024.109063.
Iding A, Alkarithi G, Ten Cate H, Ariens R, Ten Cate-Hoek A Blood Adv. 2024; 8(11):2924-2932.
PMID: 38547453 PMC: 11176944. DOI: 10.1182/bloodadvances.2023012493.